"Intensive Blood Pressure Control Benefits Nearly All CKD Patients, Study Reveals"

A study reveals that nearly all adults with chronic kidney disease can benefit from intensive blood pressure control, targeting systolic levels below 120 mm Hg, reducing risks associated with hypertension and cardiovascular disease.

• The analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) involved 2,012 participants with chronic kidney disease and assessed the benefits of targeting blood pressure below 120 mm Hg.
• Results indicate that a systolic blood pressure goal of <120 mm Hg offers significant advantages, including lower mortality rates, compared to the traditional target of <140 mm Hg.
• The findings will be presented at ASN Kidney Week 2025, highlighting the importance of effective blood pressure management in patients with chronic kidney disease to prevent complications in the circulatory system.